MedTrace Logo

Internal Radiation Therapy in Treating Patients With Prostate Cancer

NCT00573833 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2017-10-20

Study results available
· View outcomes & findings →

Summary

RATIONALE: Internal radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells.

PURPOSE: This clinical trial is studying the side effects and how well internal radiation therapy works in treating patients with prostate cancer.

Conditions

Interventions

OTHER

questionnaire administration

PROCEDURE

quality-of-life assessment

RADIATION

brachytherapy

Sponsors & Collaborators

Principal Investigators

  • Josh Yamada, MD · Memorial Sloan Kettering Cancer Center

  • Michael J. Zelefsky, MD · Memorial Sloan Kettering Cancer Center

  • Sherri M. Donat, MD · Memorial Sloan Kettering Cancer Center

  • Marco Zaider, PhD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00573833 on ClinicalTrials.gov